Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement protein C5b-C9 membrane attack complex (MAC) is a multi-protein structure formed during activation of the complement system. The MAC forms transmembrane pores in target cell membranes, leading to cell lysis and death. It is composed of C5b, C6, C7, C8, and multiple copies of C9. Excessive or misdirected activation contributes to tissue damage in autoimmune diseases. Regulation by clusterin/vitronectin prevents uncontrolled damage.
Pore formation in target cell membranes, leading to cell lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Protein C5b-C9 Membrane Attack Complex (MAC).